Global CRO Market

Transformation, Developments, Opportunities and Future of CRO Market

USD 4,950

* Required Fields

USD 4,950

PAY BY INVOICE

Be the first to review this product

This research service presents an overview and analysis of the global clinical trials and research outsourcing (CRO) market. It provides revenue forecasts for CROs globally by phase, therapeutic type, and region. It addresses the major issues and challenges, unmet needs, and emerging trends in the market. Detailed information has been provided on support services such as Central Laboratory services, Bio analytics, and Data management. It also outlines market drivers and restraints, market engineering measurements, and R&D trends. The report covers the complete life cycle of the CRO industry, starting from preclinical trials to post marketing surveillance. It highlights emerging trends and their importance in the current and future market scenario. Apart from preclinical and clinical segments it also focuses on the emerging trends than can be seen in the CRO space. One of the focus areas of this study is bio analytics services, which is making a big impact in the CRO industry. Earlier, pre-clinical and early phase research were handled by pharma companies themselves, but now, due to the high cost and risk involved, the big companies have started to look for partners, giving rise to Bio analytics focused CROs.

Table of Contents

Executive SummaryKey FindingsKey Findings (continued)Key Findings (continued)Key Findings (continued)Key Findings (continued)Global CRO Market Size by Clinical Development StageMarket Size Estimation MethodologyScope and SegmentationKey Questions This Study Will AnswerMarket Engineering MeasurementsMarket Engineering Measurements (continued)CEO’s PerspectiveKey Companies to WatchKey Companies to Watch (continued)3 Big PredictionsMarket OverviewGlobal R&D Spending—Pharmaceutical Drug DevelopmentGlobal R&D Market LandscapeGlobal Market PerspectiveCRO Product Development and Commercialization Market Segmentation by Clinical Development StageMarket Segmentation by Clinical Development Stage (continued)Market Segmentation by Therapeutic ServicesMarket Segmentation by GeographyGlobal CRO Key Market TrendseClinical SolutionseClinical Solutions—Applications and Technologies Rise of Virtual Business ModelsCompetitive PlaybookNew Market OpportunitiesNew Market Opportunities (continued)New Market Opportunities (continued)Global CRO Industry—Major Stake Holders Global CRO Competitive MatrixMerger, Acquisition, and Partnership AssessmentMerger, Acquisition, and Partnership Assessment (continued)Merger, Acquisition, and Partnership Assessment (continued)Merger, Acquisition, and Partnership Assessment (continued)External Challenges: Drivers and Restraints—Total CRO MarketMarket DriversDrivers ExplainedDrivers Explained (continued)Market RestraintsRestraints ExplainedRestraints Explained (continued)Forecasts and Trends—Total CRO MarketForecast AssumptionsMarket Engineering MeasurementsMarket Engineering Measurements (continued)Revenue ForecastRevenue Forecast DiscussionGlobal CRO Key Market TrendsGlobal CRO Key Market Trends ExplainedGlobal CRO Key Market Trends Explained (continued)Global CRO Key Market Trends Explained (continued)Competitive EnvironmentCompetitive Analysis—Market ShareMarket Share AnalysisCompetitive EnvironmentCompetitive Analysis—Selected Key Market ParticipantsCompetitive Analysis—Selected Key Market Participants (continued)Competitive Analysis—Selected Key Market Participants (continued)Competitive Analysis—Selected Key Market Participants (continued)Competitive Analysis—Selected Key Market Participants (continued)Competitive Analysis—Selected Key Market Participants (continued)Competitive Analysis—Selected Key Market Participants (continued)Competitive Analysis—Selected Key Market Participants (continued)Competitive Analysis—Selected Key Market Participants (continued)Competitive Analysis—Selected Key Market Participants (continued)CRO Segment Analysis—Preclinical Trials Segment BreakdownPreclinical Trials Segment Overview Market Engineering MeasurementsRevenue ForecastRevenue Forecast DiscussionPreclinical Trials Segment Metrics AnalysisPreclinical Trials Segment Metrics Analysis (continued)Preclinical Trials Segment Key TrendsPhase I Trials Segment BreakdownPhase I Trials Segment OverviewMarket Engineering MeasurementsRevenue ForecastRevenue Forecast DiscussionPhase I Trials Segment Metrics AnalysisPhase I Trials Segment Metrics Analysis (continued)Phase I Trials Segment Key TrendsPhase II Trials Segment Breakdown Phase II Trials Segment OverviewMarket Engineering MeasurementsRevenue ForecastRevenue Forecast DiscussionPhase II Trials Segment Metrics AnalysisPhase II Trials Segment Metrics Analysis (continued) Phase II Trials Segment Key Trends*Phase III Trials Segment BreakdownPhase III Trials Segment OverviewMarket Engineering MeasurementsRevenue ForecastRevenue Forecast DiscussionPhase III Trials Segment Metrics AnalysisPhase III Trials Segment Metrics Analysis (continued)Phase III Trials Segment Key Trends*Phase IV Trials Segment BreakdownPhase IV Trials Segment OverviewMarket Engineering MeasurementsRevenue ForecastPhase IV Trials Segment—Revenue Forecast DiscussionPhase IV Trials Segment Metrics AnalysisPhase IV Trials Segment Metrics Analysis (continued)Phase IV Trials Segment Key TrendsData Management Segment BreakdownData Management Segment OverviewMarket Engineering MeasurementsRevenue ForecastRevenue ForecastData Management Segment Metrics AnalysisData Management Segment Metrics Analysis (continued)Data Management Segment Key TrendsBiostatistics Segment BreakdownBiostatistics Segment OverviewEngineering MeasurementsRevenue ForecastRevenue Forecast DiscussionBiostatistics Segment Metrics AnalysisBiostatistics Segment Metrics Analysis (continued)Biostatistics Segment Key TrendsPharmacovigilance Segment BreakdownPharmacovigilance Segment OverviewMarket Engineering MeasurementsRevenue ForecastRevenue Forecast DiscussionPharmacovigilance Segment Metrics AnalysisPharmacovigilance Segment Metrics Analysis (continued)Pharmacovigilance Segment Key TrendsHealth Economics and Outcomes Research (HEOR) Segment BreakdownHEOR Segment OverviewMarket Engineering MeasurementsRevenue ForecastRevenue Forecast DiscussionHEOR Segment Metrics AnalysisHEOR Segment Metrics Analysis (continued)HEOR Segment Key TrendsPharmaceuticals and Biotech Laboratory Testing Service SegmentPharmaceuticals and Biotech Laboratory Testing Services Segment—OverviewPharmaceuticals and Biotech Laboratory Services—Segmentation Pharmaceuticals and Biotech Laboratory Testing Services—Segmentation (continued)Pharmaceuticals and Biotech Laboratory Testing Services—Key TrendsPharmaceuticals and Biotech Laboratory Services—Key Trends ExplainedPharmaceuticals and Biotech Laboratory Services—Key Trends Explained (continued)Analytical Testing Services—cGMP Testing SegmentcGMP Testing Segment OverviewMarket Engineering MeasurementsRevenue ForecastRevenue Forecast DiscussioncGMP Testing Segment Metrics AnalysiscGMP Testing Segment Metrics Analysis (continued)Revenue Breakdown by Type of ServicesAnalytical Testing Services—Bio-analytical Testing SegmentBio-analytical Testing Segment OverviewMarket Engineering MeasurementsRevenue ForecastRevenue Forecast DiscussionBio-analytical Testing Segment Metrics AnalysisBio-analytical Testing Segment Metrics Analysis (continued)Revenue Breakdown by Type of ServicesAnalytical Testing Services SegmentCompetitive EnvironmentAnalytical Testing Services—Major ParticipantsAnalytical Testing Services—Market ShareAnalytical Testing Services—Market Share AnalysisAnalytical Testing Services—Competitive EnvironmentCompetitive Analysis—Selected Key Market ParticipantsCompetitive Analysis—Selected Key Market Participants (continued)Competitive Analysis—Selected Key Market Participants (continued)Competitive Analysis—Selected Key Market Participants (continued)Competitive Analysis—Selected Key Market Participants (continued)Competitive Analysis—Selected Key Market Participants (continued)Central Laboratory Testing Segment BreakdownCentral Laboratory Testing Segment OverviewMarket Engineering MeasurementsRevenue ForecastRevenue Forecast DiscussionCentral Laboratory Testing Segment Metrics AnalysisCentral Laboratory Testing Segment Metrics Analysis (continued)Regional Breakdown—North America CRO Market OverviewNorth America BreakdownSegmentation by Clinical Development StageSegmentation by Therapeutic ServicesNorth America CRO Market size by Clinical Development StageMarket Engineering MeasurementsRevenue ForecastNorth America CRO Market—Revenue Forecast DiscussionNorth America Segment Analysis by PhasesPreclinical and Phase I Trials Segment—Revenue ForecastPhase II and Phase III Trials Segment—Revenue ForecastPhase IV Trials and Pharmacovigilance Segment—Revenue ForecastBiostatistics and Data Management Segment—Revenue ForecastBio-analytical and Central Laboratory Testing Segment—Revenue ForecastHEOR Segment—Revenue ForecastMarket ShareEurope CRO Market OverviewEurope BreakdownSegmentation by Clinical Development StageSegmentation by Therapeutic ServicesEurope CRO Market size by Clinical Development StageMarket Engineering MeasurementsRevenue ForecastRevenue Forecast DiscussionEurope Segment Analysis by PhasesPreclinical and Phase I Trials Segment—Revenue ForecastPhase II and Phase III Trials Segment—Revenue ForecastPhase IV Trials and Pharmacovigilance Segment—Revenue ForecastBiostatistics and Data Management Segment—Revenue ForecastBio-analytical and Central Laboratory Testing Segment—Revenue ForecastHEOR Segment—Revenue ForecastMarket ShareAPAC CRO Market OverviewAPAC BreakdownSegmentation by Clinical Development StageSegmentation by Therapeutic ServicesMarket size by Clinical Development StageMarket Engineering MeasurementsRevenue ForecastRevenue Forecast DiscussionAPAC Segment Analysis by PhasesPreclinical and Phase I Trials Segment—Revenue ForecastPhase II and Phase III Trials Segment—Revenue ForecastPhase IV Trials and Pharmacovigilance Segment—Revenue ForecastBiostatistics and Data Management Segment—Revenue ForecastBio-analytical and Central Laboratory Testing Segment—Revenue ForecastHEOR Segment—Revenue ForecastMarket ShareROW CRO Market OverviewROW BreakdownSegmentation by Clinical Development StageSegmentation by Therapeutic ServicesMarket size by Clinical Development StageMarket Engineering MeasurementsRevenue ForecastROW CRO Market—Revenue Forecast DiscussionROW Segment Analysis by PhasesPreclinical and Phase I Trials Segment—Revenue ForecastPhase II and Phase III Trials Segment—Revenue ForecastPhase IV Trials and Pharmacovigilance Segment—Revenue ForecastBiostatistics and Data Management Segment—Revenue ForecastBio-analytical and Central Laboratory Testing Segment—Revenue ForecastHEOR Segment—Revenue ForecastMarket ShareThe Last Word3 Big PredictionsThe Last Word—DiscussionLegal DisclaimerAppendixMarket Engineering MethodologyList of ExhibitsList of Exhibits (continued)List of Exhibits (continued)List of Exhibits (continued)List of Exhibits (continued)List of Exhibits (continued)List of Exhibits (continued)List of Exhibits (continued)List of Exhibits (continued)List of Exhibits (continued)List of Exhibits (continued)

Infographic





Keyword1

Keyword2

Keyword3

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.